FDA Approves Chenodiol for Treatment of Cerebrotendinous Xanthomatosis
Ctexli is the first FDA-approved treatment for adults with cerebrotendinous xanthomatosis.
FDA Says Ozempic, Wegovy Shortage Resolved
Semaglutide has been in shortage since 2022 due to increased demand.
Q&A: Innovative Technologies Revolutionizing Pain Medicine
Physician with expertise in pain research discussed emerging technologies in the future of pain medicine and how they must be adapted to improve patient outcomes.
Texas Health Department Investigating Measles Outbreak as Case Count Reaches 90
Measles is highly contagious, and the Texas Department of State Health Services said that additional cases are likely to occur in Gaines County, which had 57 cases as of February 21, 2025.
Multimodal Regimen Crucial for Treating Burn Injury-Induced Pain
Experts gathered to explore the pathophysiology and therapeutic management of burn injury-induced pain.
Tirzepatide Shows Substantial Weight Loss for Patients With Type 1 Diabetes
Tirzepatide (Mounjaro, Zepbound), a glucagon-like peptide-1 (GLP-1) medication, demonstrates improved diabetes control and decreases in insulin requirements.
Cardiovascular Practice Program Could Help Pharmacists Lower Patient Blood Pressure
A program that includes peer coaching and monitoring tools can help pharmacists better manage hypertension in patients.
Entrepreneurship Necessary to Community Pharmacy Practice, Education
Researchers conducted a literature review to explore topics in entrepreneurship that impact pharmacy practice and education.
Type 1 Diabetes Linked With Increased Dementia Risk
A recent metanalysis found that patients with type 1 diabetes had a 50% higher chance of developing dementia.
FDA Grants Breakthrough Therapy Designation to SkinTE for Wagner Grade 1 Diabetic Foot Ulcers
By 12 weeks, investigators report that SkinTE facilitated significantly more wound closures compared with the standard of care.
Q&A: Pharmacist Prescribed Contraception Can Mitigate Barriers to Care
A conversation with Ginger Lemay, PharmD, Jeffrey Bratberg, PharmD, and Audrey Whalen, PharmD.
Community Pharmacies Motivated to Adopt Opioid Overdose Prevention Practices
Researchers measured current pharmacy practices and the future potential of practices geared toward reducing instances of opioid overdose.
ChatGPT Could Help Community Pharmacists Save Time
Researchers conducted a survey of community pharmacists to understand their use, concerns, and opportunities regarding ChatGPT technology in their practice setting.
FDA Accepts New Drug Application for Vatiquinone to Treat Friedreich Ataxia
The FDA also granted priority review, with a Prescription Drug User Fee Act target action date of August 19, 2025.
GLP-1 Oral Tablet Shows Favorable Safety Findings in Patients With Obesity
ASC30, an investigational glucagon-like 1-peptide receptor agonist, demonstrates mean weight reductions from baseline of 4.3% and 6.3% for 2 separate cohorts.
FDA to Evaluate Lenacapavir for Prevention of HIV
A PDUFA target action date for the PrEP therapy has been set for June 19, 2025.
Cryotherapy Spray Reduced Pain, Improved Joint Mobility
Patients with musculoskeletal pain were treated with cryotherapy spray to assess its use in providing immediate and sustained pain relief.
Maximum (Un)Fair Price
How pharmacies will pay for the Medicare Drug Price Negotiation Program
Deucravacitinib Safety, Efficacy for Plaque Psoriasis Remains Consistent Up to 5 Years
The FDA initially approved deucravacitinib (Sotyktu) in September 2022 to treat moderate-to-severe plaque psoriasis.
Your 2025 Pharmacy Legislation Update
Explore key legislative actions changing pharmacy practice in 2025 and beyond.
Buprenorphine Option Did Not Improve Pain, Reduce Opioid Dosage
Patients prescribed high-dose opioids were given the option to switch to buprenorphine in hopes of improving pain and reducing opioid dosage.
FDA Accepts sBLA for Dupilumab for Bullous Pemphigoid
Previously, dupilumab (Dupixent) received orphan drug designation for bullous pemphigoid.
ICER Finds Insurers Struggled to Provide Fair Access to Obesity Drugs
The Institute for Clinical and Economic Review assessed the formularies of 11 payers, covering 57 million people, to determine access to drugs that the organization had reviewed for cost effectiveness in 2022.
Esketamine Safe, Effective for Treating Postoperative Pain
Researchers investigate the effects of subanesthetic doses of esketamine for the treatment of pain and cognition in patients undergoing surgery.
FDA Approves Recombinant Chikungunya Vaccine, Vimkunya
The vaccine is the first virus-like particle single-dose vaccine for chikungunya for patients 12 years and older.
Automated Insulin Delivery Significantly Lowered A1c for Patients With T2D
Among a diverse cohort of patients with type 2 diabetes (T2D), researchers examined the use of automated insulin delivery for lowering hemoglobin A1c levels.
FDA Approves Denosumab-Dssb as Biosimilar for Prolia, Xgeva
Denosumab-dssb is approved as a 60 mg pre-filled syringe as a biosimilar for Prolia and 120 mg vial as a biosimilar for Xgeva.
FDA Approves MenABCWY Vaccine for Patients Ages 10 to 25 Years
The combination includes 2 previously approved vaccines to target the 5 major serogroups of Neisseria meningitidis.
Vaccine Administration in Pharmacies, Nontraditional Clinics Could Help Increase Access
In order to meet national targets, the United States should expand vaccination administration in complementary sites like pharmacies.
New Test Could Help Identify Patients That Would Benefit From Blood Thinners
Currently, blood-thinning medications are only prescribed to patients who have already had a heart attack or stroke, as the drugs can cause serious bleeding.
